Skip to main content
Top
Published in: World Journal of Surgery 5/2020

Open Access 01-05-2020 | Gastric Surgery | Original Scientific Report

Improvement in Hyperglycemia Prevents Surgical Site Infection Irrespective of Insulin Therapy in Non-diabetic Patients Undergoing Gastrointestinal Surgery

Authors: Ayami Yoneda, Yoshio Takesue, Yoshiko Takahashi, Kaoru Ichiki, Toshie Tsuchida, Hiroki Ikeuchi, Motoi Uchino, Etsuro Hatano, Hisashi Shinohara, Naohiro Tomita

Published in: World Journal of Surgery | Issue 5/2020

Login to get access

Abstract

Background

Intensive glycemic control is recommended to prevent surgical site infections (SSI). Our aim was to evaluate retrospectively the effect of improvement in hyperglycemia irrespective of insulin use on the incidence of SSI in non-diabetic patients.

Methods

The highest blood glucose (BG) concentration within 12 h (early peak BG) and the final BG from 12 to 24 h after surgery were evaluated in patients who underwent gastrointestinal surgery. Patients with an early peak BG of ≥150 mg/dL were divided into those with persistent (final BG of ≥150 mg/dL) and improved hyperglycemia (final BG of <150 mg/dL). Patients without hyperglycemia and those with late-onset hyperglycemia were also assessed for SSI risk.

Results

Overall, 1612 patients were studied (diabetes, n = 293). Although hyperglycemia increased the SSI rates in non-diabetic patients, no correlation was demonstrated in patients with diabetes at any cutoff final BG defining htperglycemia except for 180 mg/dL. Hyperglycemia improved without insulin therapy in 283 of 512 non-diabetic patients who had early hyperglycemia. The adjusted standardized residual for those with SSI and persistent hyperglycemia was 5.2 (P < 0.05). In contrast, the absence of hyperglycemia was a significant preventive factor for SSI. In the multivariate analyses, persistent hyperglycemia was an independent risk factor for SSI (odds ratio 1.54; 95% confidence interval 1.03–2.31).

Conclusions

Remission of hyperglycemia within 24 h after surgery prevented SSI in non-diabetic patients. Considering that hyperglycemia improved in approximately half of patients without insulin therapy, commencement of insulin dosing after two consecutive BGs of ≥150 mg/dL might be reasonable, especially in general wards.
Literature
1.
go back to reference de Vries FE, Gans SL, Solomkin JS et al (2016) Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection. Br J Surg 104:e95–e105CrossRef de Vries FE, Gans SL, Solomkin JS et al (2016) Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection. Br J Surg 104:e95–e105CrossRef
2.
go back to reference Ata A, Lee J, Bestle SL, Desemone J et al (2010) Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 145:858–864CrossRef Ata A, Lee J, Bestle SL, Desemone J et al (2010) Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 145:858–864CrossRef
3.
go back to reference Okabayashi T, Shima Y, Sumiyoshi T et al (2014) Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care 37:1516–1524CrossRef Okabayashi T, Shima Y, Sumiyoshi T et al (2014) Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care 37:1516–1524CrossRef
4.
go back to reference Shanks AM, Woodrum DT, Kumar SS et al (2018) Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery. BMC Anesthesiol 18:90CrossRef Shanks AM, Woodrum DT, Kumar SS et al (2018) Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery. BMC Anesthesiol 18:90CrossRef
5.
go back to reference Showen A, Russell TA, Young S et al (2017) Hyperglycemia is associated with surgical site infections among general and vascular surgery patients. Am Surg 83:1108–1111PubMed Showen A, Russell TA, Young S et al (2017) Hyperglycemia is associated with surgical site infections among general and vascular surgery patients. Am Surg 83:1108–1111PubMed
6.
go back to reference Duggan EW, Carlson K, Umpierrez GE (2017) Perioperative hyperglycemia management: an update. Anesthesiology 2017(126):547–560CrossRef Duggan EW, Carlson K, Umpierrez GE (2017) Perioperative hyperglycemia management: an update. Anesthesiology 2017(126):547–560CrossRef
7.
go back to reference Wang YY, Hu SF, Ying HM, Chen L et al (2018) Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysis. BMC Endocr Disord 18:42CrossRef Wang YY, Hu SF, Ying HM, Chen L et al (2018) Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysis. BMC Endocr Disord 18:42CrossRef
8.
go back to reference Ban KA, Minei JP, Laronga C et al (2017) American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update. J Am Coll Surg 224:59–74CrossRef Ban KA, Minei JP, Laronga C et al (2017) American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update. J Am Coll Surg 224:59–74CrossRef
9.
go back to reference Peacock TS (2019) Perioperative hyperglycemia: a literature review. AORN J 109:80–86CrossRef Peacock TS (2019) Perioperative hyperglycemia: a literature review. AORN J 109:80–86CrossRef
11.
go back to reference Farrokhi F, Smiley D, Umpierrez GE (2011) Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab 25:813–824CrossRef Farrokhi F, Smiley D, Umpierrez GE (2011) Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab 25:813–824CrossRef
12.
go back to reference Kotagal M, Symons RG, Hirsch IB et al (2015) Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg 261:97–103CrossRef Kotagal M, Symons RG, Hirsch IB et al (2015) Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg 261:97–103CrossRef
13.
go back to reference Frisch A, Chandra P, Smiley D, Peng L et al (2010) Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 33:1783–1788CrossRef Frisch A, Chandra P, Smiley D, Peng L et al (2010) Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 33:1783–1788CrossRef
14.
go back to reference Berríos-Torres SI, Umscheid CA, Bratzler DW et al (2017) Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152:784–791CrossRef Berríos-Torres SI, Umscheid CA, Bratzler DW et al (2017) Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152:784–791CrossRef
15.
go back to reference Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRef Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRef
Metadata
Title
Improvement in Hyperglycemia Prevents Surgical Site Infection Irrespective of Insulin Therapy in Non-diabetic Patients Undergoing Gastrointestinal Surgery
Authors
Ayami Yoneda
Yoshio Takesue
Yoshiko Takahashi
Kaoru Ichiki
Toshie Tsuchida
Hiroki Ikeuchi
Motoi Uchino
Etsuro Hatano
Hisashi Shinohara
Naohiro Tomita
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 5/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05371-y

Other articles of this Issue 5/2020

World Journal of Surgery 5/2020 Go to the issue